[ITCI] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[ITCI] Intra-Cellular Therapies, Inc.
Announcement Date
30-Oct-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -62.29%
YoY- -8.52%
Quarter Report
ITCI's Result
ITCI's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 175,375 125,810 71,870 21,606 7,369 0 0 -
PBT -25,950 -24,215 -53,507 -76,931 -55,184 -34,862 -41,523 -7.52%
Tax -374 43 1 -23 -1,506 -1,514 -1,868 -23.49%
NP -26,324 -24,258 -53,508 -76,908 -55,184 -34,862 -41,523 -7.30%
Tax Rate - - - - - - - -
Total Cost 201,699 150,068 125,378 98,514 62,552 34,862 41,523 30.10%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -15.01 -19.28 -74.45 -355.95 -748.90 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.25 -0.25 -0.57 -0.95 -0.79 -0.63 -0.76 -16.90%
EPS Diluted -0.25 -0.25 -0.57 -0.95 -0.79 -0.63 -0.76 -16.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.